In 2017, Biohaven was in need of clinical pharmacology and pharmacometrics expertise for Nurtec to supplement their drug development team. They engaged with Certara because of our proven experience in clinical pharmacology and pharmacometrics.
Certara was able to fill the gaps and worked closely alongside Biohaven’s scientists to use quantitative methods to advance Nurtec’s path to approval.